KP Trayes, SEH Cokenakes - American family physician, 2021 - aafp.org
Breast cancer is the leading cause of death from cancer in women worldwide, and the second most common cause of death from cancer in women in the United States. Risk …
WJ Gradishar, MS Moran, J Abraham, R Aft… - Journal of the National …, 2022 - jnccn.org
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …
TJ Whelan, S Smith, S Parpia, AW Fyles… - … England Journal of …, 2023 - Mass Medical Soc
Background Adjuvant radiotherapy is prescribed after breast-conserving surgery to reduce the risk of local recurrence. However, radiotherapy is inconvenient, costly, and associated …
AM Brunt, JS Haviland, DA Wheatley, MA Sydenham… - The Lancet, 2020 - thelancet.com
Background We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as …
R Orecchia, U Veronesi, P Maisonneuve… - The Lancet …, 2021 - thelancet.com
Background In the randomised, phase 3 equivalence trial on electron intraoperative radiotherapy (ELIOT), accelerated partial breast irradiation (APBI) with the use of …
Objective To determine whether risk adapted intraoperative radiotherapy, delivered as a single dose during lumpectomy, can effectively replace postoperative whole breast external …
J Haussmann, S Corradini, C Nestle-Kraemling… - Radiation …, 2020 - Springer
Radiation therapy is an integral part of the multidisciplinary management of breast cancer. Regional lymph node irradiation in younger trials seems to provide superior target coverage …
PURPOSE The Standardized Definitions for Efficacy End Points (STEEP) criteria, established in 2007, provide standardized definitions of adjuvant breast cancer clinical trial …